# Doximity, Inc. – Consensus ‘hold’ rating and 18.1% Upside Potential

- Link: https://www.directorstalkinterviews.com/doximity-inc.consensus-hold-rating-and-18.1-upside-potential/4121129768
- Published: 2023-10-13T14:52:21+01:00
- Author: Charlotte Edwards

**Doximity, Inc.** with ticker code (DOCS) have now 10 confirmed analysts covering
the stock with the consensus suggesting a rating of ‘hold’. The target price High/
Low ranges between 30 and 21 suggesting an average Analsyt target price of $26.30.
Now with the previous closing price of $22.27 this would imply there is now a potential
upside of 18.1%. The day 50 moving average is $23.22 and the 200 day moving average
is $30.85. The market capitalization for the company is 4.22B. The current share
price for the company is: 21.67 USD

 The potential market cap would be $4,982,957,373 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 38.02, revenue per share of 2.26
and a 7.61% return on assets.

Doximity, Inc. provides a digital platform for United States (U.S) medical professionals.
The Company’s cloud-based platform provides tools to its members, which help them
to collaborate with colleagues, coordinate patient care, conduct virtual patient
visits, stay up-to-date with medical news and research, and manage careers. The 
Company supports physicians in practice of medicine with mobile and clinical workflow
tools, such as voice and video telehealth, secure messaging and digital faxing. 
The Company’s platform offers marketing, hiring, and telehealth solutions. Its marketing
solutions enable pharmaceutical and health system customers to get content, services,
and peer connections to medical professionals through a variety of modules. Its 
hiring solutions provide digital recruiting capabilities to health systems and medical
recruiting firms. Its telehealth solutions consist of software tools that include
voice and video dialers, designed to connect patients with care providers.

Share on:
